FMR LLC - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 95 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$2,525,000
-61.6%
2,623,077
-52.5%
0.00%
-100.0%
Q1 2022$6,576,000
-77.7%
5,526,376
-39.0%
0.00%
-50.0%
Q4 2021$29,539,000
-27.1%
9,061,297
+0.0%
0.00%
-33.3%
Q3 2021$40,493,000
-17.9%
9,058,845
+0.1%
0.00%
-25.0%
Q2 2021$49,311,000
-26.9%
9,047,965
+0.4%
0.00%
-33.3%
Q1 2021$67,433,000
-6.4%
9,015,112
+35.8%
0.01%0.0%
Q4 2020$72,053,000
+22.9%
6,640,835
+0.1%
0.01%0.0%
Q3 2020$58,641,000
-16.9%
6,633,550
+0.2%
0.01%
-25.0%
Q2 2020$70,603,000
+89.6%
6,623,200
+5.5%
0.01%
+60.0%
Q1 2020$37,234,000
-12.2%
6,278,984
+2.3%
0.01%0.0%
Q4 2019$42,396,000
-33.4%
6,135,409
+0.0%
0.01%
-37.5%
Q3 2019$63,681,000
+12.1%
6,134,961
+0.0%
0.01%
+14.3%
Q2 2019$56,805,000
+23.1%
6,134,442
+21.5%
0.01%
+16.7%
Q1 2019$46,140,000
+64.1%
5,048,1580.0%0.01%
+50.0%
Q4 2018$28,118,000
-53.2%
5,048,1580.0%0.00%
-42.9%
Q3 2018$60,124,000
+20.5%
5,048,158
+3.3%
0.01%
+16.7%
Q2 2018$49,894,000
-20.4%
4,886,748
+1.2%
0.01%
-14.3%
Q1 2018$62,682,000
+63.3%
4,829,094
+22.4%
0.01%
+75.0%
Q4 2017$38,380,000
-33.8%
3,944,465
+0.1%
0.00%
-42.9%
Q3 2017$57,983,000
-8.2%
3,939,030
+0.3%
0.01%
-12.5%
Q2 2017$63,185,000
+13.0%
3,926,998
+11.9%
0.01%
+14.3%
Q1 2017$55,897,000
+31.1%
3,508,937
+0.1%
0.01%
+16.7%
Q4 2016$42,646,000
-12.3%
3,507,070
+0.0%
0.01%0.0%
Q3 2016$48,631,000
+28.5%
3,506,155
+15.8%
0.01%
+20.0%
Q2 2016$37,841,0003,027,2850.01%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders